Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn’s disease: a prospective cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn’s disease: a prospective cohort study

Published:2003-07 Issue:1 Volume:125 Page:32-39
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Vermeire Severine,Noman Maja,Van Assche Gert,Baert Filip,Van Steen Kristel,Esters Nele,Joossens Sofie,Bossuyt Xavier,Rutgeerts Paul

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn’s disease;Targan;N Engl J Med,1997

2. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease;Rutgeerts;Gastroenterology,1999

3. Maintenance infliximab for Crohn’s disease;Hanauer;Lancet,2002

4. Infliximab for the treatment of fistulas in patients with Crohn’s disease;Present;N Engl J Med,1999

5. Review article: safety of infliximab in clinical trials;Hanauer;Aliment Pharmacol Ther,1999

Cited by 291 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAPEFLM Paper;Diagnostyka Laboratoryjna;2024-05-19

2. Clinical Pharmacology in Sarcoidosis: How to Use and Monitor Sarcoidosis Medications;Journal of Clinical Medicine;2024-02-22

3. Disproportional signal of pericarditis with biological diseasemodifying antirheumatic drugs (bDMARDs) in patients with ankylosing spondylitis: a disproportionality analysis in the FAERS database;Frontiers in Pharmacology;2024-01-25

4. Autoimmune Haemolytic Anaemia as a Rare and Potentially Serious Complication of Crohn’s Disease in a 11-Year-Old Child—Case Report and Minireview;Children;2023-10-17

5. Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature;World Journal of Cardiology;2023-05-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3